Basil Rigas
Overview
Explore the profile of Basil Rigas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
1815
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Basu A, Yang J, Tsirukis V, Loiacono A, Koch G, Khwaja I, et al.
Front Neurosci
. 2024 Feb;
17:1240372.
PMID: 38347876
Background: Chemotherapy-induced peripheral neuropathy (CIPN), a side effect of chemotherapy, is particularly difficult to treat. We explored whether phosphosulindac (PS), a modified NSAID, could treat CIPN. Methods: CIPN was induced...
2.
Huang W, Huang L, Wen Z, Honkanen R, Rigas B
J Ocul Pharmacol Ther
. 2023 May;
39(4):279-289.
PMID: 37172294
To evaluate the hypothesis that 3 novel compounds, OXT-328, Q-922, and CL-717 show efficacy in the treatment of oxygen-induced retinopathy (OIR) and whether or not their route of administration is...
3.
Huang W, Huang L, Li W, Saglam M, Tourmouzis K, Goldstein S, et al.
J Ocul Pharmacol Ther
. 2021 Dec;
38(1):102-113.
PMID: 34964663
Dry eye disease (DED) is classified as aqueous deficient, evaporative, or mixed. We investigated the therapeutic effect of the novel anti-inflammatory drug phosphosulindac (PS) in rabbit models of DED encompassing...
4.
Master A, Huang W, Huang L, Honkanen R, Rigas B
Curr Eye Res
. 2021 Nov;
47(1):41-50.
PMID: 34841993
Purpose: To develop a more efficient impression cytology (IC) method for the transfer of ocular surface cells onto glass microscope slides for cytochemical, immunocytochemical, and immunofluorescence studies. Methods: Cells are...
5.
Master A, Huang W, Huang L, Li W, Saglam S, Honkanen R, et al.
Exp Eye Res
. 2021 Nov;
213:108827.
PMID: 34742691
Drug development, resource- and time-intensive, extensively employs cell-based assays to assess the efficacy and safety of candidate drugs. The widely used immortalized cell lines, experimentally convenient, have limited predictive value....
6.
Huang W, Tourmouzis K, Perry H, Honkanen R, Rigas B
Exp Ther Med
. 2021 Oct;
22(6):1394.
PMID: 34650642
Dry eye disease (DED), which is a prevalent disease that still lacks successful treatment options, remains a major challenge in ophthalmology. Multiple animal models of DED have been used to...
7.
Master A, Kontzias A, Huang L, Huang W, Tsioulias A, Zarabi S, et al.
PLoS One
. 2021 Jul;
16(7):e0254036.
PMID: 34324523
The pathophysiology of dry eye disease (DED) remains largely unknown, accounting in part for the lack of successful treatments. We explored the pathophysiology of DED using a rabbit model of...
8.
Huang W, Wen Z, Saglam M, Huang L, Honkanen R, Rigas B
J Ocul Pharmacol Ther
. 2021 Jun;
37(6):321-330.
PMID: 34152861
Inflammation of the ocular surface is central to dry eye disease (DED). The anti-inflammatory agent phospho-sulindac (PS) at a high dose was efficacious against DED in a rabbit model. We...
9.
Honkanen R, Nemesure B, Huang L, Rigas B
Curr Eye Res
. 2021 Jan;
46(5):622-629.
PMID: 33445973
Purpose: To evaluate whether principal component analysis (PCA) can assess various diagnostic tests of dry eye disease (DED), providing a simplified, more informative measure of disease status than individual clinical...
10.
Honkanen R, Huang L, Rigas B
J Vis Exp
. 2020 Feb;
(155).
PMID: 32065120
Dry eye disease (DED), a multifactorial inflammatory disease of the ocular surface, affects 1 in 6 humans worldwide with staggering implications for quality of life and health care costs. The...